FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

372740001: Centrally acting hypotensive agent (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1198035011 Centrally acting hypotensive agent (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1211263018 Centrally acting hypotensive agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3011879010 Centrally acting antihypertensive agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1198035011 Centrally acting hypotensive agent (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1198035011 Centrally acting hypotensive agent (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1211263018 Centrally acting hypotensive agent en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1211263018 Centrally acting hypotensive agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3011879010 Centrally acting antihypertensive agent en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3011879010 Centrally acting antihypertensive agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Centrally acting hypotensive agent Is a Hypotensive agent (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Syrosingopine (substance) Is a True Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Reserpine - chemical Is a False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Rescinnamine Is a True Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Alpha-2 adrenergic receptor agonist Is a False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Product containing alpha-2 adrenergic receptor agonist (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Product containing deserpidine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Dexmedetomidine hydrochlorid 100mcg/mL injection (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely deserpidine 250 microgram and methyclothiazide 5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely deserpidine 500 microgram and methyclothiazide 5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Centrally acting hypotensive agent The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Product containing reserpine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Reserpine 100% The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Chlorothiazide 500 mg and reserpine 125 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 25 mg and reserpine 125 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrochlorothiazide 50 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Product containing chlorothiazide and reserpine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Product containing hydrochlorothiazide and reserpine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Product containing deserpidine and methyclothiazide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Product containing hydralazine hydrochloride and hydrochlorothiazide and reserpine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Product containing methyclothiazide and reserpine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely guanfacine hydrochloride 1 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Chlorothiazide 250 mg and methyldopa 250 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Clonidine-containing product in transdermal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Guanfacine hydrochloride 1mg extended release tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Apraclonidine 1% intra-ocular solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Clonidine 100microgram extended release film The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Clonidine hydrochloride 100mcg/mL injection solution 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Product containing clonidine in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely lofexidine hydrochloride 200 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Product containing chlortalidone and clonidine hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Product containing dexmedetomidine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Methyldopa 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Clonidine hydrochloride 100 microgram/mL prolonged-release oral suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Guanfacine hydrochloride 4mg extended release tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Clonidine 7.5mg/unt The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Clonidine 2.5mg/unt The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Product containing guanabenz (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 25 mg and methyldopa 250 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Clonidine 200microgram extended release film The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Clonidine hydrochloride 150micrograms/1mL injection (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely guanfacine hydrochloride 2 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Apraclonidine (as apraclonidine hydrochloride) 5 mg/mL eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Apraclonidine-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Methyldopa 250 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Product containing guanfacine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 30 mg and methyldopa 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Clonidine-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Guanfacine hydrochloride 3mg extended release tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 15 mg and methyldopa 250 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Clonidine 5mg patch The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Clonidine 0.1mg patch The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Chlortalidone 15 mg and clonidine hydrochloride 200 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Clonidine hydrochloride 0.5mg/mL injection solution 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Clonidine hydrochloride 100 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely guanabenz acetate 8 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Guanfacine hydrochloride 2mg extended release tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Product containing clonidine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Clonidine hydrochloride 300micrograms tablet (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Methyldopa 125 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Chlorthalidone + clonidine hydrochloride 15mg/0.3mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Guanabenz acetate 4 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Product containing guanfacine hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Methyldopa 250 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Product containing hydrochlorothiazide and methyldopa (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Methyldopa-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Clonidine 300microgram extended release film The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Product containing lofexidine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Clonidine 4mg/patch The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Chlorothiazide- and methyldopa-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Clonidine hydrochloride 250micrograms m/r capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Clonidine hydrochloride 0.2mg tablet (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely clonidine hydrochloride 25 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Methyldopa-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)
Product containing central alpha-adrenoceptor agonist The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Centrally acting hypotensive agent Inferred relationship Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start